To determine the role of SHMT2 in BLCA, we verified that both SHMT2 mRNA and protein expression levels were overexpressed in BLCA tissues and cell lines (SW780, 5637, and T24). Here, SHMT2 is linked to bladder transitional cell carcinoma.